2m 2m 2m 2m 2m 2m 2m
CAPRICOR THERAP (CAPR)
NASDAQ
$3.81-$0.04 (-0.99%)
Price as of Aug 03, 2026 10:19 AM EDT- $223.0MMarket Cap
- -51.27%1-Year Change
- BiotechnologyIndustry
CAPRICOR THERAP (CAPR)
$3.81-$0.04 (-0.99%)
CAPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.85 | ||
Change | -$0.34 (-8.11%) | ||
Open | $4.04 | ||
High | $4.66 | ||
Low | $3.80 | ||
Previous Close | $4.19 | ||
Volume | 7,297,140 | ||
30-Day Average Volume | 5,249,083 | ||
1-Week Change | -80.46% | ||
1-Month Change | -84.01% | ||
1-Year Change | -51.27% | ||
3-Year Change | -12.50% | ||
5-Year Change | -11.90% | ||
Fundamentals | |||
Shares Outstanding | 57.9M | ||
Total Assets | $326.3M | ||
Market Cap | $223.0M | ||
Enterprise Value | $117.5M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$33.9M | ||
Free Cash Flow | -$34.4M | ||
EBIT | -$33.9M | ||
EBITDA | -$33.4M | ||
Net Working Capital | $249.5M | ||
EPS | -$0.59 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | -1 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/05/2019 | ||
Earnings & Revenue